These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4315461)

  • 1. Macrophages and age-dependent resistance to Herpes simplex virus in mice.
    Hirsch MS; Zisman B; Allison AC
    J Immunol; 1970 May; 104(5):1160-5. PubMed ID: 4315461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Herpes simplex virus and macrophages].
    Scieux C
    Pathol Biol (Paris); 1997 Feb; 45(2):159-64. PubMed ID: 9247038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of macrophages and macrophage cytokines in host resistance to herpes simplex virus.
    Hendrzak JA; Morahan PS
    Immunol Ser; 1994; 60():601-17. PubMed ID: 7504529
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.
    Nagafuchi S; Oda H; Mori R; Taniguchi T
    J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 6. Host defences in mice against infections with herpes simplex virus.
    Mogensen SC
    Microbiol Sci; 1984 Aug; 1(5):127-30. PubMed ID: 6086079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus recombinants as potential herpes simplex virus vaccines.
    Rooney JF; Wohlenberg CR; Notkins AL
    Adv Exp Med Biol; 1992; 327():183-9. PubMed ID: 1338264
    [No Abstract]   [Full Text] [Related]  

  • 10. Cells infected with herpes simplex virus induce human monocyte-macrophages to produce interferon.
    Stanwick TL; Campbell DE; Nahmias AJ
    Immunobiology; 1981; 158(3):207-12. PubMed ID: 6163697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte interferon production and transformation after Herpes simplex infections in humans.
    Rasmussen LE; Jordan GW; Stevens DA; Merigan TC
    J Immunol; 1974 Feb; 112(2):728-36. PubMed ID: 4360547
    [No Abstract]   [Full Text] [Related]  

  • 13. [Host immune response to herpes simplex virus infection].
    Hayashi K
    Uirusu; 1989 Jun; 39(1):1-19. PubMed ID: 2481368
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of trauma on production of herpes interferon in guinea pigs.
    Tokumaru T
    Arch Gesamte Virusforsch; 1967; 21(1):61-70. PubMed ID: 4300369
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune control of herpes simplex virus infections.
    Ennis FA; Wells M
    Cancer Res; 1974 May; 34(5):1140-5. PubMed ID: 4546304
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of herpes simplex virus gB-specific cytotoxic T lymphocytes in TAP1-deficient mice by genetic immunization but not HSV infection.
    Paliard X; Doe B; Selby MJ; Hartog K; Lee AY; Burke RL; Walker CM
    Virology; 2001 Mar; 282(1):56-64. PubMed ID: 11259190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    Nash AA; Phelan J; Wildy P
    J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The continuing problem of herpes simplex virus persistence.
    Rajcáni J; Szántó J
    Acta Virol; 1983 Sep; 27(5):442-50. PubMed ID: 6139950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.